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agricultural settings may be at a crossroad. It is well-recognized that AR application is the only 48 current method for rapid and effective eradication of "established " rodent infestations. 8 
ADVERSE OUTCOME PATHWAY FOR ANTICOAGULANT RODENTICIDES

60
An AOP is a conceptual framework portraying existing knowledge as a logical sequence of 61 processes linking a direct molecular initiating event to an adverse effect across multiple levels of 62 biological organization, which is relevant in risk assessment. [17] [18] [19] In an ecological context, is related to the length and hydrophobicity of the side chain at carbon 13, with the most active 85 compounds having greater volume and bulky lipophilic groups in this activity domain ( Figure   86 2). warfarin resistance is at Y139; common mutations include substitutions of S, C, and F, for Y.
119
Other common mutations that afford warfarin resistance are indicated in yellow. In the U.S. EPA's comparative risk analysis, the FGARs seemed to be less hazardous to 279 both target and non-target species. 80 Some of this analysis relied on acute toxicity data.
280
However, an acute exposure scenario is neither appropriate nor environmentally relevant (i.e., FGARs (warfarin, chlorophacinone) exceeded levels of concern for non-target birds and 296 mammals. Consumption of SGAR-exposed prey also exceeded levels of concern for predatory 297 birds and mammals. While consumption of FGAR-exposed prey posed a hazard for non-target 298 mammals, levels of concern were rarely exceeded for birds. 4 In some use scenarios (e.g.,
299
Rozol® for control of prairie dogs, Cynomys ludovicianus), label requirements even state that 300 applicators must make multiple follow-up visits after application to remove dead or dying target 301 species to mitigate hazard to non-target scavengers and predators. 86 Such practices to reduce 302 potential AR exposure of predators may not always be followed. 86 
UNSOLVED ISSUES
380
There are significant unknowns related to exposure and effects to predatory wildlife associated 381 with use of ARs. Among these are basic and applied data needs to supplement risk assessments.
382
Some of these data are best derived from controlled exposure trials using captive animals, while 383 other information can only be generated from field observations and hypothesis-driven eco-384 epidemiological studies, and even a combination of these activities. source is presumed to be of human origin. However, based on both its low concentration and log
422
K ow (2.37), it is highly unlikely that this is a significant source of exposure for predatory wildlife.
423
Macromolecular to Population-Level Effects. could be a major factor in AR susceptibility and tolerance.
438
Controlled AR exposure studies have principally focused on overt signs of toxicity and 439 mortality, occasionally included measurement of AR residues and sublethal responses (e.g.,
440
behavior, condition, histopathology), and rarely quantification of blood clotting. 72, 80, 126 There contained AR residues, only 6% could be diagnosed as having succumbed from AR toxicosis. AOP for ARs as they relate to non-target predatory species, it is apparent that the "mechanism of 566 action" from the molecular through cellular levels of organization is well-understood. However, 
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